Virtual Reality Headset and/or Aromatherapy for Patients Undergoing a Transperineal Prostate Biopsy

Launched by UNIVERSITY OF PITTSBURGH · Feb 28, 2024

Keywords

ClinConnect Summary

This clinical trial is exploring whether using a virtual reality (VR) headset and/or aromatherapy can help reduce pain, anxiety, and embarrassment for men undergoing a transperineal prostate biopsy, a procedure used to collect tissue samples from the prostate. The study compares the experiences of participants who use VR, those who experience aromatherapy, those who use both, and a control group receiving standard care. Researchers want to understand how these methods affect feelings of pain, fear, and embarrassment during and after the procedure.

To participate in this trial, men aged 18 and older who are scheduled for a transperineal prostate biopsy can consider joining. However, those with certain conditions, such as severe mental health issues, significant hearing or vision problems, a history of seizures, or bad reactions to strong smells, may not be eligible. Participants can expect to be part of a supportive environment where their experiences with pain and anxiety will be monitored, helping to find better ways to make this procedure more comfortable.

Gender

MALE

Eligibility criteria

• Inclusion Criteria:
• • Patient is 18 years or older
• • Patient is male
• • Patient is due for a transperineal prostate biopsy
• • Patient signed and dated informed consent form on Redcap agreeing to participate in the study
• Exclusion Criteria:
• • Patient has a known psychiatric or mental illness that would impede use of the VR device or aromatherapy patch
• • Patient has severe hearing or vision problems that would impair use of the VR headset (under the physician's discretion)
• • Patient has a history of seizures or epilepsy or is on a medication that would lower the threshold for a seizure
• • Patient has a history of reactions to noxious odors